Prevalence of High-Risk Prostate Cancer Metastasis to Cloquet’s Ilioinguinal Lymph Node. Letter.

No AccessJournal of UrologyLetters to the Editor1 Apr 2023Prevalence of High-risk Prostate Cancer Metastasis to Cloquet’s Ilioinguinal Lymph Node. Letter.is a letter which has replyPrevalence of High-risk Prostate Cancer Metastasis to Cloquet’s Ilioinguinal Lymph Node. Reply. Hilda A. de Barros, Anne-Claire Berrens, Maarten L. Donswijk, Esther M. K. Wit, Fijs W. B. van Leeuwen, Pim J. van Leeuwen, and Henk G. van der Poel Hilda A. de BarrosHilda A. de Barros *Correspondence: Plesmanlaan 121, 1066CXAmsterdam, The Netherlands telephone: +31 25129111; E-mail Address: [email protected] https://orcid.org/0000-0003-2102-7897 Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands More articles by this author , Anne-Claire BerrensAnne-Claire Berrens Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands More articles by this author , Maarten L. DonswijkMaarten L. Donswijk Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands More articles by this author , Esther M. K. WitEsther M. K. Wit Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands More articles by this author , Fijs W. B. van LeeuwenFijs W. B. van Leeuwen Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands More articles by this author , Pim J. van LeeuwenPim J. van Leeuwen Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands More articles by this author , and Henk G. van der PoelHenk G. van der Poel Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003177AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Prevalence of High-risk Prostate Cancer Metastasis to Cloquet’s Ilioinguinal Lymph Node. Letter.." The Journal of Urology, 209(4), p. 681 References 1. . Prevalence of high-risk prostate cancer metastasis to Cloquet's ilioinguinal lymph node. J Urol. 2022; 207(6):1222-1226. Link, Google Scholar 2. . Extended pelvic lymphadenectomy for prostate cancer: should the Cloquet's nodes dissection be considered only an option?. Minerva Urol Nefrol. 2019; 71(2):136-145. Crossref, Medline, Google Scholar 3. . Laparoscopic sentinel lymph node biopsy for prostate cancer: the relevance of locations outside the extended dissection area. Prostate Cancer. 2012; 2012:751753. Crossref, Medline, Google Scholar 4. . Lymph node fluorescence during robot-assisted radical prostatectomy with indocyanine green: prospective dosing analysis. Clin Genitourinary Cancer. 2017; 15(4):e529-e534. Crossref, Medline, Google Scholar 5. . Can intraoperative fluorescence imaging identify all lesions while the road map created by preoperative nuclear imaging is masked?. J Nucl Med. 2020; 61(6):834-841. Crossref, Medline, Google Scholar © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology19 Jan 2023Prevalence of High-risk Prostate Cancer Metastasis to Cloquet’s Ilioinguinal Lymph Node. Reply. Volume 209Issue 4April 2023Page: 681-681 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Hilda A. de Barros Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands *Correspondence: Plesmanlaan 121, 1066CXAmsterdam, The Netherlands telephone: +31 25129111; E-mail Address: [email protected] More articles by this author Anne-Claire Berrens Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands More articles by this author Maarten L. Donswijk Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands More articles by this author Esther M. K. Wit Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands More articles by this author Fijs W. B. van Leeuwen Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands More articles by this author Pim J. van Leeuwen Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands More articles by this author Henk G. van der Poel Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands Netherlands Prostate Cancer Network, Amsterdam, The Netherlands Department of Urology, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands More articles by this author Expand All Advertisement PDF downloadLoading ...